Clinical Trial Update: Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating masitinib in combination with gemcitabine for advanced/metastatic pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Masitinib (masitinib)

Snippet

Sponsor: AB Science | Conditions: Pancreatic Cancer | Phase 3 | Status: COMPLETED